Cosmo Pharmaceuticals N.V. (SWX: COPN)
Switzerland
· Delayed Price · Currency is CHF
64.20
+0.50 (0.78%)
Jan 3, 2025, 5:31 PM CET
Cosmo Pharmaceuticals Revenue
Cosmo Pharmaceuticals had revenue of 136.24M EUR in the half year ending June 30, 2024, with 228.19% growth. This brings the company's revenue in the last twelve months to 185.36M, up 77.82% year-over-year. In the year 2023, Cosmo Pharmaceuticals had annual revenue of 92.78M, down -9.12%.
Revenue (ttm)
185.36M EUR
Revenue Growth
+77.82%
P/S Ratio
5.79
Revenue / Employee
570.33K EUR
Employees
325
Market Cap
1.03B CHF
Revenue Chart
* This company reports financials in EUR.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 92.78M | -9.31M | -9.12% |
Dec 31, 2022 | 102.09M | 37.02M | 56.88% |
Dec 31, 2021 | 65.07M | 4.13M | 6.77% |
Dec 31, 2020 | 60.95M | -1.55M | -2.47% |
Dec 31, 2019 | 62.50M | -3.12M | -4.76% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Roche Holding AG | 60.58B |
Novartis AG | 42.18B |
Lonza Group AG | 6.70B |
Alcon | 8.25B |
Galderma Group AG | 3.88B |
Straumann Holding AG | 2.54B |
Sonova Holding AG | 3.71B |
Sandoz Group AG | 9.09B |
Cosmo Pharmaceuticals News
- 3 months ago - Cosmo Pharmaceuticals gets new finance chief - Seeking Alpha